 BILLERICA, Mass., April 22, 2021 GLOBE NEWSWIRE -- Conformis, Inc. NASDAQ:CFMS announced today that it received 510k clearance by the U.S. Food and Drug Administration for patient-specific instrumentation PSI developed by the Company under its License Agreement and Development Agreement with Howmedica Osteonics Corp., a wholly owned subsidiary of Stryker Corporation also known as Stryker Orthopaedics. With the clearance of this PSI system, which is designed for use with Strykers Triathlon Total Knee System, the Company has achieved the third of three milestones under the agreements and will receive 11.0 million from Stryker. 